With major NPEs quietly adopting Chinese litigation as part of their global monetisation strategies, the results so far indicate that patent quality is paramount
Returning user?
Enter your details below to log into your account.
Want to read more?
Register to access two of our subscriber only articles per month.
@IAM_Alerts RT @IAM_Alerts: The Biden Administration’s decision to support a suspension of covid vaccine IP rights raises powerful concerns that go way… Read more
